Detailed answers about NEUROPAIN LIMITED, including incorporation, status, business activity, and accounts information.
When was NEUROPAIN LIMITED founded?
NEUROPAIN LIMITED was officially incorporated on 5 June 2015 and is registered under company number 09625230. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEUROPAIN LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEUROPAIN LIMITED?
NEUROPAIN LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEUROPAIN LIMITED do?
NEUROPAIN LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is NEUROPAIN LIMITED's registered address?
The registered office address of NEUROPAIN LIMITED is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEUROPAIN LIMITED financially stable?
The most recent accounts for NEUROPAIN LIMITED were made up to 30 June 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 March 2026.